% alzhub.org library filter % Source: https://alzhub.org/research?journal=Pharmaceuticals+%28Basel%2C+Switzerland%29 % 8 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{castelloguillen2026-8eff1361, author = {Castello-Guillen, A. and Garrido-Reig, M. and Caplliure-Llopis, J. and Vega-Bello, M. J. and Almela, C. and de la Rubia Ortí, J. E.}, title = {{Efficacy of Curcumin in Neurodegenerative Diseases: From Pharmacokinetic Barriers to Advanced Delivery Systems}}, journal = {Pharmaceuticals (Basel, Switzerland)}, year = {2026}, doi = {10.20944/preprints202608.1026.v1}, url = {https://doi.org/10.20944/preprints202608.1026.v1} } @article{terao2024-39598397, author = {Terao, Takeshi and Hirakawa, Hirofumi and Muronaga, Masaaki and Izumi, Toshihiko and Kohno, Kentaro}, title = {{Trace Lithium for Suicide Prevention and Dementia Prevention: A Qualitative Review}}, journal = {Pharmaceuticals (Basel, Switzerland)}, year = {2024}, doi = {10.3390/ph17111486}, pmid = {39598397}, url = {https://doi.org/10.3390/ph17111486} } @article{vanderoovaart2023-38004378, author = {Van de Roovaart, Hannah J and Nguyen, Nguyen and Veenstra, Timothy D}, title = {{Huntington's Disease Drug Development: A Phase 3 Pipeline Analysis}}, journal = {Pharmaceuticals (Basel, Switzerland)}, year = {2023}, doi = {10.3390/ph16111513}, pmid = {38004378}, url = {https://doi.org/10.3390/ph16111513} } @article{jie2021-33573211, author = {Jie, C. V. M. L. and Treyer, V. and Schibli, R. and Mu, L.}, title = {{Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease}}, journal = {Pharmaceuticals (Basel, Switzerland)}, year = {2021}, doi = {10.3390/ph14020110}, pmid = {33573211}, url = {https://doi.org/10.3390/ph14020110} } @article{maia2019-30893882, author = {Maia, M. A. and Sousa, E.}, title = {{BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer's Disease}}, journal = {Pharmaceuticals (Basel, Switzerland)}, year = {2019}, doi = {10.3390/ph12010041}, pmid = {30893882}, url = {https://doi.org/10.3390/ph12010041} } @article{duraes2018-29751602, author = {Durães, F. and Pinto, M. and Sousa, E.}, title = {{Old Drugs as New Treatments for Neurodegenerative Diseases}}, journal = {Pharmaceuticals (Basel, Switzerland)}, year = {2018}, doi = {10.3390/ph11020044}, pmid = {29751602}, url = {https://doi.org/10.3390/ph11020044} } @article{martins2020-32933034, author = {Martins, Márcia and Silva, Renata and Pinto, Madalena M M and Sousa, Emília}, title = {{Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer's Disease}}, journal = {Pharmaceuticals (Basel, Switzerland)}, year = {2020}, doi = {10.3390/ph13090242}, pmid = {32933034}, url = {https://doi.org/10.3390/ph13090242} } @article{aleksandar2024-39770490, author = {Aleksandar, Jovalekic and Santiago, Bullich and Núria, Roé-Vellvé and Domingues, Kolinger Guilherme and Howard Lorelei, R. and Floriana, Elsholz and Mariana, Lagos-Quintana and Beatriz, Blanco-Rodriguez and others}, title = {{Experiences from Clinical Research and Routine Use of Florbetaben Amyloid PET-A Decade of Post-Authorization Insights}}, journal = {Pharmaceuticals (Basel, Switzerland)}, year = {2024}, doi = {10.3390/ph17121648}, pmid = {39770490}, url = {https://doi.org/10.3390/ph17121648} }